No gene acts alone: interacting variants and protein partnerships can worsen, mask or even rescue disease risk, demanding ...

How big of a role do our genes play in our lifespan? Quite a bit more than previously thought, a new study suggests.

Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Q4 2025 Earnings Call Transcript January 30, 2026 Regeneron Pharmaceuticals, Inc. beats earnings expectations. Reported EPS is $11.44, expectations were ...

A deep dive into the Fc–FcR axis as a therapeutic anchor in autoimmune disease, examining immune signaling and drug ...

As 'Strongest Berberine for Weight Loss,' 'Best Berberine Supplement,' and 'Nature's Ozempic' Search Phrases Peak in 2026, ...

The pharmaceutical sector continues to evolve at an unprecedented pace. In this dynamic environment, where hundreds of ...

The farming community of Abrewankor in the Yilo Krobo Municipality of the Eastern Region has inaugurated a state-of-the-art ...

If the Giants want to build on the young core foundation they have, they need to make a strong effort to bring back these ...

There is a growing frustration and anxiety among parents over perceived developmental regression in children following routine vaccinations, raising ...

Fourth quarter 2025 revenues increased 3% to $3.9 billion versus fourth quarter 2024; full year 2025 revenues increased 1% to $14.3 billion versus 2024Fourth quarter 2025 Dupixent- global net sales ...

DelveInsight provides structured pharma conference coverage solutions designed to help industry leaders to track and interpret critical developments emerging from major healthcare conferences.

Cancer evolves through layers of change: mutations in DNA, shifts in gene regulation, altered cell behaviour, and dynamic ...